Viral Disease :: Hand-foot-mouth outbreak in Linyi update – 2nd child died
A viral hand-foot-and-mouth disease killed a 14-month-old boy in eastern China’s Shandong province, state media reported.
A viral hand-foot-and-mouth disease killed a 14-month-old boy in eastern China’s Shandong province, state media reported.
Most people do their best to avoid mosquitoes. But this summer Rollie Clem will play the wary host to his own homegrown swarm of Aedes aegypti, the yellow fever mosquito. He’s made a room ready for them, and even a menu.
Researchers at the University of Minnesota and the University of Illinois at Urbana-Champaign have developed a new therapeutic that neutralizes Toxic Shock Syndrome (TSS) more effectively than other treatments.
A rapid diagnostic test capable of detecting and identifying viruses such as Dengue, Yellow Fever and Japanese encephalitis (JEV) has been developed that has significantly reduced the time and discomfort involved with diagnosing an infection.
UT Southwestern Medical Center has joined a national clinical trial to identify the long-term health effects of West Nile virus infection and to learn more about the disease’s progression, symptoms and mortality.
Michigan based meat company has initiated recall of 129,000 pounds of beef products in 15 states in the United States because of possible E. coli contamination.
Many school children in the United States memorize President Abraham Lincoln’s Gettysburg Address, considered one of history’s most brilliant speeches and a model of brevity and persuasive rhetoric.
The effort to contain deadly yellow fever, recently resurgent in West Africa, received a boost today at the annual policy meeting of the United Nations health agency, with the launch of an immunization campaign backed by a $58 million contribution.
Developing new strategies to prevent and control yellow fever and dengue fever has become more possible with the completion of the first draft of the genome sequence of Aedes aegypti mosquito by scientists led by Vishvanath Nene at The Institute for Genomic Research (TIGR) and David Severson at the University of Notre Dame.
Hospitalized patients with community-acquired pneumonia who received treatment regimens against atyical disease-causing pathogens reached clinical stability quicker, had fewer days of hospitalization and had lower mortality rates as a result of their disease, according to a large new study.